Cargando…

Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer’s disease

Alzheimer’s Disease (AD) and atherosclerosis remain two of the largest public health burdens in the world today. Although traditionally considered distinct pathological entities, mounting epidemiologic, clinical and experimental evidence suggests that cerebrovascular atherosclerosis and AD interact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Ajay, Iadecola, Costantino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468824/ https://www.ncbi.nlm.nih.gov/pubmed/26136682 http://dx.doi.org/10.3389/fnagi.2015.00115

Ejemplares similares

Interaction between therapeutic interventions for Alzheimer’s disease and physiological Aβ clearance mechanisms
por: Morrone, Christopher D., et al.
Publicado: (2015)

Th17 and Cognitive Impairment: Possible Mechanisms of Action
por: Cipollini, Virginia, et al.
Publicado: (2019)

Aβ Clearance, “hub” of Multiple Deficiencies Leading to Alzheimer Disease
por: Gallina, Pasquale, et al.
Publicado: (2015)

Evidence for impaired amyloid β clearance in Alzheimer's disease
por: Wildsmith, Kristin R, et al.
Publicado: (2013)

Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology
por: Thal, Dietmar R.
Publicado: (2015)

Editorial: Clearance Pathways for Amyloid-β. Significance for Alzheimer's Disease and Its Therapy
por: Carare, Roxana O.
Publicado: (2017)

Erythrocytes as Potential Link between Diabetes and Alzheimer’s Disease
por: Carelli-Alinovi, Cristiana, et al.
Publicado: (2017)

Alzheimer’s Disease and Vascular Aging: JACC Focus Seminar
por: Cortes-Canteli, Marta, et al.
Publicado: (2020)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer’s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2013)

The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
por: Kanekiyo, Takahisa, et al.
Publicado: (2014)

Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer’s disease
por: González-Marrero, Ibrahim, et al.
Publicado: (2015)

Aluminum-Induced Amyloidogenesis and Impairment in the Clearance of Amyloid Peptides from the Central Nervous System in Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2014)

In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein
por: McIntee, Farron L., et al.
Publicado: (2016)

Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer’s disease: the role, regulation and restoration of LRP1
por: Ramanathan, Anita, et al.
Publicado: (2015)

Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
por: Kim, Dong Eun, et al.
Publicado: (2020)

ROCK1 Is Associated with Alzheimer’s Disease-Specific Plaques, as well as Enhances Autophagosome Formation But not Autophagic Aβ Clearance
por: Hu, Yong-Bo, et al.
Publicado: (2016)

Tau Clearance Mechanisms and Their Possible Role in the Pathogenesis of Alzheimer Disease
por: Chesser, Adrianne S., et al.
Publicado: (2013)

The Gastrointestinal Tract Microbiome and Potential Link to Alzheimer’s Disease
por: Hill, James M., et al.
Publicado: (2014)

HIV Neuroinfection and Alzheimer’s Disease: Similarities and Potential Links?
por: Canet, Geoffrey, et al.
Publicado: (2018)

Dihydroartemisinin Ameliorates Learning and Memory in Alzheimer’s Disease Through Promoting Autophagosome-Lysosome Fusion and Autolysosomal Degradation for Aβ Clearance
por: Zhao, Yueyang, et al.
Publicado: (2020)

Dityrosine cross-linking and its potential roles in Alzheimer’s disease
por: Maina, Mahmoud B., et al.
Publicado: (2023)

Hijacking PrP(c)-dependent signal transduction: when prions impair Aβ clearance
por: Hernandez-Rapp, Julia, et al.
Publicado: (2014)

The role of microglia and myeloid immune cells in acute cerebral ischemia
por: Benakis, Corinne, et al.
Publicado: (2015)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

Plasma lipocalin-2 levels in the preclinical stage of Alzheimer's disease
por: Eruysal, Emily, et al.
Publicado: (2019)

Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
por: Ferreira, Sergio T., et al.
Publicado: (2015)

Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer’s Disease
por: Yoon, Sang-Sun, et al.
Publicado: (2012)

Unlocking the enigma: unraveling multiple cognitive dysfunction linked to glymphatic impairment in early Alzheimer’s disease
por: Zhong, Jiayi, et al.
Publicado: (2023)

Microglia activation linking amyloid-β drive tau spatial propagation in Alzheimer's disease
por: Wang, Qing, et al.
Publicado: (2022)

Mechanisms of Aβ Clearance and Degradation by Glial Cells
por: Ries, Miriam, et al.
Publicado: (2016)

Mild behavioral impairment linked to progression to Alzheimer’s disease and cortical thinning in amnestic mild cognitive impairment
por: Yoon, Eun Jin, et al.
Publicado: (2023)

Human Nmnat1 Promotes Autophagic Clearance of Amyloid Plaques in a Drosophila Model of Alzheimer’s Disease
por: Zhu, Yi, et al.
Publicado: (2022)

The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease
por: Viola, Kirsten L., et al.
Publicado: (2022)

Over-Expressed Pathogenic miRNAs in Alzheimer’s Disease (AD) and Prion Disease (PrD) Drive Deficits in TREM2-Mediated Aβ42 Peptide Clearance
por: Zhao, Yuhai, et al.
Publicado: (2016)

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
por: Mullins, Roger J., et al.
Publicado: (2017)

Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model
por: Harrison, Ian F, et al.
Publicado: (2020)

Ergothioneine, a dietary antioxidant improves amyloid beta clearance in the neuroretina of a mouse model of Alzheimer’s disease
por: Wijesinghe, Printha, et al.
Publicado: (2023)

Nogo receptor impairs the clearance of fibril amyloid‐β by microglia and accelerates Alzheimer’s‐like disease progression
por: Wang, Jianing, et al.
Publicado: (2021)

The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies
por: Gonçalves, Rafaella Araujo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cff2rvh3nkjbdlri1ikqr94jpn